Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 139

Similar articles for PubMed (Select 24225272)

1.

No evidence of an increase in early infant mortality from congenital adrenal hyperplasia in the absence of screening.

Hird BE, Tetlow L, Tobi S, Patel L, Clayton PE.

Arch Dis Child. 2014 Feb;99(2):158-64. doi: 10.1136/archdischild-2013-304473. Epub 2013 Nov 13.

PMID:
24225272
2.

Increased cardiovascular and metabolic morbidity in patients with 21-hydroxylase deficiency: a Swedish population-based national cohort study.

Falhammar H, Frisén L, Linden Hirschberg A, Norrby C, Almqvist C, Nordenskjöld A, Nordenström A.

J Clin Endocrinol Metab. 2015 Jun 30:JC20152093. [Epub ahead of print]

PMID:
26126207
3.

Classic Congenital Adrenal Hyperplasia due to 21-Hydroxylase-Deficiency: 13 Years of Neonatal Screening and Follow-up in Bavaria.

Odenwald B, Dörr HG, Bonfig W, Schmidt H, Fingerhut R, Wildner M, Nennstiel-Ratzel U.

Klin Padiatr. 2015 Jun 19. [Epub ahead of print]

PMID:
26090996
4.

Congenital adrenal hyperplasia and the function of adrenal medulla.

Lisá L, Bílek R, Vrzalová Z.

Horm Mol Biol Clin Investig. 2010 Aug 1;2(2):245-8. doi: 10.1515/HMBCI.2010.030.

PMID:
25961196
5.

Therapy monitoring in congenital adrenal hyperplasia by dried blood samples.

Wieacker I, Peter M, Borucki K, Empting S, Roehl FW, Mohnike K.

J Pediatr Endocrinol Metab. 2015 Mar 7. pii: /j/jpem.ahead-of-print/jpem-2014-0303/jpem-2014-0303.xml. doi: 10.1515/jpem-2014-0303. [Epub ahead of print]

PMID:
25781526
6.

Large testicular adrenal rest tumours in a patient with congenital adrenal hyperplasia.

Rajkanna J, Oyibo SO.

Endocrinol Diabetes Metab Case Rep. 2015;2015:140080. doi: 10.1530/EDM-14-0080. Epub 2015 Feb 1.

7.

Phenotypic variability of hyperandrogenemia in females heterozygous for CYP21A2 mutations.

Neocleous V, Shammas C, Phedonos AA, Phylactou LA, Skordis N.

Indian J Endocrinol Metab. 2014 Nov;18(Suppl 1):S72-9. doi: 10.4103/2230-8210.145077.

8.

Newborn screening for congenital adrenal hyperplasia in New Zealand, 1994-2013.

Heather NL, Seneviratne SN, Webster D, Derraik JG, Jefferies C, Carll J, Jiang Y, Cutfield WS, Hofman PL.

J Clin Endocrinol Metab. 2015 Mar;100(3):1002-8. doi: 10.1210/jc.2014-3168. Epub 2014 Dec 12.

PMID:
25494862
9.

Genetic defects of the CYP21A2 gene in girls with premature adrenarche.

Skordis N, Shammas C, Phedonos AA, Kyriakou A, Toumba M, Neocleous V, Phylactou LA.

J Endocrinol Invest. 2014 Dec 7. [Epub ahead of print]

PMID:
25481255
10.

[Multicenter investigation on the impact of newborn infants' gestational age and birth weight on the level of 17α-hydroxyprogesterone].

Zhang Q, Wang B, Chen Y, Jiang D, Chen Y.

Zhonghua Er Ke Za Zhi. 2014 Sep;52(9):706-9. Chinese.

PMID:
25476436
11.

Ten-year evaluation of a Neonatal Screening Program for congenital adrenal hyperplasia.

Nascimento ML, Cristiano AN, Campos Td, Ohira M, Cechinel E, Simoni G, Lee Jv, Linhares RM, Silva PC.

Arq Bras Endocrinol Metabol. 2014 Oct;58(7):765-71.

12.

Hormonal disturbances due to severe and mild forms of congenital adrenal hyperplasia are already detectable in neonatal life.

Faurschou S, Mouritsen A, Johannsen TH, Hougaard DM, Cohen A, Duno M, Juul A, Main KM.

Acta Paediatr. 2015 Feb;104(2):e57-62. doi: 10.1111/apa.12835. Epub 2014 Nov 17.

PMID:
25346389
13.

A rare CYP 21 mutation (p.E431K) induced deactivation of CYP 21A2 and resulted in congenital adrenal hyperplasia.

Kawashima Y, Usui T, Fujimoto M, Miyahara N, Nishimura R, Hanaki K, Kanzaki S.

Endocr J. 2015;62(1):101-6. doi: 10.1507/endocrj.EJ14-0437. Epub 2014 Oct 15.

14.

Increased mortality in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.

Falhammar H, Frisén L, Norrby C, Hirschberg AL, Almqvist C, Nordenskjöld A, Nordenström A.

J Clin Endocrinol Metab. 2014 Dec;99(12):E2715-21. doi: 10.1210/jc.2014-2957.

PMID:
25279502
15.

3β-hydroxysteroid dehydrogenase type II deficiency on newborn screening test.

Araújo VG, Oliveira RS, Gameleira KP, Cruz CB, Lofrano-Porto A.

Arq Bras Endocrinol Metabol. 2014 Aug;58(6):650-5.

16.

Decreased adrenomedullary function in infants with classical congenital adrenal hyperplasia.

Kim MS, Ryabets-Lienhard A, Bali B, Lane CJ, Park AH, Hall S, Geffner ME.

J Clin Endocrinol Metab. 2014 Aug;99(8):E1597-601. doi: 10.1210/jc.2014-1274. Epub 2014 May 30.

PMID:
24878051
17.

Reduced activity of 11β-hydroxylase accounts for elevated 17α-hydroxyprogesterone in preterms.

Kamrath C, Hartmann MF, Boettcher C, Wudy SA.

J Pediatr. 2014 Aug;165(2):280-4. doi: 10.1016/j.jpeds.2014.04.011. Epub 2014 May 23.

PMID:
24862381
18.

Results from 28 years of newborn screening for congenital adrenal hyperplasia in sapporo.

Morikawa S, Nakamura A, Fujikura K, Fukushi M, Hotsubo T, Miyata J, Ishizu K, Tajima T.

Clin Pediatr Endocrinol. 2014 Apr;23(2):35-43. doi: 10.1297/cpe.23.35. Epub 2014 Apr 20.

19.

Nationwide neonatal screening for congenital adrenal hyperplasia in sweden: a 26-year longitudinal prospective population-based study.

Gidlöf S, Wedell A, Guthenberg C, von Döbeln U, Nordenström A.

JAMA Pediatr. 2014 Jun;168(6):567-74. doi: 10.1001/jamapediatrics.2013.5321.

PMID:
24733564
20.

17-Hydroxyprogesterone in children, adolescents and adults.

Honour JW.

Ann Clin Biochem. 2014 Jul;51(Pt 4):424-40. doi: 10.1177/0004563214529748. Epub 2014 Apr 7.

PMID:
24711560
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk